Screener
IDEAYA Biosciences, Inc. IDYA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Short-term marketable securities | 513,679 | 526,563 |
| Prepaid expenses and other current assets | 18,346 | 21,366 |
| Contract assets | 6,560 | 5,973 |
| Total current assets | 696,107 | 666,727 |
| Restricted cash | 1,281 | 1,015 |
| Long-term marketable securities | 301,713 | 410,297 |
| Property and equipment, net | 8,634 | 8,217 |
| Right-of-use assets | 22,613 | 23,068 |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s total current assets?
- IDEAYA Biosciences, Inc. (IDYA) reported total current assets of $696.11M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s total current assets changed year-over-year?
- IDEAYA Biosciences, Inc.'s total current assets decreased by 1.7% year-over-year, from $707.87M to $696.11M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s total current assets?
- Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s total current assets has grown at a 18.2% compound annual growth rate (CAGR), from $288.61M to $666.73M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about IDEAYA Biosciences, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude